Saito Tsukasa, Amakusa Yoshinobu, Kimura Takashi, Yahara Osamu, Aizawa Hitoshi, Ikeda Yoshio, Day John W, Ranum Laura P W, Ohno Kinji, Matsuura Tohru
Department of Neurology, National Dohoku Hospital, Asahikawa, Japan.
Neurogenetics. 2008 Feb;9(1):61-3. doi: 10.1007/s10048-007-0110-4. Epub 2007 Dec 5.
Myotonic dystrophy type 2 (DM2) is caused by expansion of a tetranucleotide CCTG repeat in intron 1 of the ZNF9 gene on chromosome 3q21. All studied DM2 mutations have been reported in Caucasians and share an identical haplotype, suggesting a common founder. We identified a Japanese patient with DM2 and showed that the affected haplotype is distinct from the previously identified DM2 haplotype shared among Caucasians. These data strongly suggest that DM2 expansion mutations originate from separate founders in Europe and Japan and are more widely distributed than previously recognized.
2型强直性肌营养不良症(DM2)是由位于3号染色体q21区域的ZNF9基因内含子1中的四核苷酸CCTG重复序列扩增引起的。所有已研究的DM2突变均在白种人中被报道,且共享相同的单倍型,提示存在一个共同的奠基者突变。我们鉴定出一名患有DM2的日本患者,并发现其受累单倍型与先前在白种人中鉴定出的共享DM2单倍型不同。这些数据强烈表明,DM2扩增突变在欧洲和日本起源于不同的奠基者突变,且分布比之前认为的更为广泛。